首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1824241

生物資訊市場 - 預測 2025-2030

Bioinformatics Market - Forecasts from 2025 to 2030

出版日期: 2025年08月22日 | 出版商:

Knowledge Sourcing Intelligence | 英文 156 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

生物資訊市場規模：

生物資訊市場預計將從 2025 年的 151.34 億美元成長到 2030 年的 303.61 億美元，複合年成長率為 14.94%。

生物資訊學代表了計算科學與生物學研究的融合，它運用先進的分析工具來處理和解讀複雜的生物資料集。這個跨學科領域涵蓋基因和蛋白質功能的計算分析、演化關係的繪製以及蛋白質結構的預測，並已成為現代生物學研究和醫學應用的重要組成部分。

市場動態和產業背景

隨著先進的序列測定和蛋白質分析技術產生的數據呈指數級成長，調查方法已成為生物學研究的關鍵推動力。這個領域的重要性源自於對海量生物資料集進行管理、解讀並從中獲取有意義見解的根本需求，而這些資料集的規模之大，已經超出了傳統分析能力的範疇。

現代生物學研究產生了前所未有的海量基因組學、蛋白質組學和代謝組學數據，這些數據需要先進的計算基礎設施和專門的分析演算法。如此複雜的數據需要先進的研究解決方案，這些解決方案不僅要能夠處理多維資料集，還要為醫學應用和持續的研究進展提供準確且可操作的洞察。

市場的擴張反映出人們日益認知到計算生物學在加速科學發現、藥物開發和個人化醫療方面的作用。隨著生物研究的數據密集度日益提高，生物資訊學平台已成為從基礎研究到臨床應用的重要基礎設施。

成長要素和投資趨勢

公共和私營部門投資

政府機構和私人企業大力投資，透過運算解決方案提升生物研究能力，生物資訊市場因此受益匪淺。這些投資體現了他們對生物資訊學潛力的策略性認知，即透過先進的數據分析和新技術提供高品質的研究成果。

這種投資模式體現了其致力於建構全面的生物資訊學生態系統的決心，該生態系統旨在支持從基礎生物學研究到應用醫學研究的各類研究應用。此類資金支持有助於開發複雜的生物數據分析所需的先進分析平台、資料庫基礎設施和計算資源。

公共部門對生物資訊學的資助尤其凸顯了該領域對國家研究重點、公共衛生計畫和科學競爭力的重要性。私部門的投資透過刺激商業性生物資訊解決方案和專業分析服務的創新，補充了政府資金。

市場限制和實施挑戰

技術成本障礙

生物資訊產業面臨與先進分析設備和複雜軟體平台高成本相關的重大挑戰。次世代定序技術及其相關的運算基礎設施需要大量的資金投入，這可能會限制小型機構的市場准入。

對於基因組學設備而言，成本是一個特別重要的考慮因素，先進的系統價格昂貴，以反映其先進的功能和分析能力。對於預算有限的小型製藥公司和研究機構來說，購買多台基因組分析儀器的資金需求可能是一個重大障礙。

這些成本限制會造成市場分割，只有資金充足的研究機構才能充分利用尖端能力，從而限制廣泛的市場擴張和整個研究界的創新傳播。

技術複雜性和可用性挑戰

生物資訊市場在軟體可用性和技術可近性方面持續面臨挑戰。許多生物資訊學應用需要豐富的計算專業知識，這給缺乏專業程式設計技能但需要分析能力的實驗研究人員帶來了障礙。

複雜的分析能力與使用者友善介面之間的脫節限制了生物資訊學工具在科學研究領域的廣泛應用。由於大多數實驗研究人員缺乏正規的生物資訊學培訓，因此直覺易用的軟體設計對於市場拓展至關重要。

目前的生物資訊學平台通常缺乏足夠的使用者介面來彌補計算複雜性與實際研究應用之間的差距。這種可用性方面的差距限制了那些能夠從生物資訊學功能中獲益但缺乏操作複雜軟體環境技術專業知識的研究人員的採用，從而限制了市場的成長。

戰略市場展望

生物資訊市場處於一個動態的環境中，其特徵是資料複雜性不斷增加，但成本和可近性的挑戰卻不斷增加。在先進的分析能力和使用者友善的介面之間取得平衡，同時解決限制不同研究機構進入市場的成本障礙，是成功的關鍵。

本報告的主要優點

深入分析：深入了解主要和新興地區的市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
競爭格局：了解主要企業所採用的策略策略，並了解採用正確的策略的市場滲透潛力。
市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
可行的建議：利用洞察力進行策略決策，並在動態環境中開闢新的業務流和收益。
適合廣泛的使用者：對於新興企業、研究機構、顧問、中小企業和大型企業來說都是有益且具有成本效益的。

它有什麼用途？

產業與市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

調查範圍

2022 年至 2024 年的歷史數據和 2025 年至 2030 年的預測數據
成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
競爭定位、策略和市場佔有率分析
收益成長和預測細分市場和區域分析（包括國家）
公司概況（尤其是財務狀況和關鍵發展）。

介紹
北美洲
- 按用途
- 依生物資料類型
- 按最終用戶
- 按國家
  - 美國
  - 加拿大
  - 墨西哥
南美洲
- 按用途
- 依生物資料類型
- 按最終用戶
- 按國家
  - 巴西
  - 阿根廷
  - 其他
歐洲
- 按用途
- 依生物資料類型
- 按最終用戶
- 按國家
  - 英國
  - 德國
  - 法國
  - 西班牙
  - 其他
中東和非洲
- 按用途
- 依生物資料類型
- 按最終用戶
- 按國家
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 其他
亞太地區
- 按用途
- 依生物資料類型
- 按最終用戶
- 按國家
  - 中國
  - 日本
  - 印度
  - 韓國
  - 台灣
  - 其他

第9章競爭格局及分析

主要企業和策略分析
市佔率分析
合併、收購、協議和合作
競爭對手儀表板

第10章：公司簡介

Thermo Fisher Scientific Inc.
Illumina Inc.
QIAGEN NV
Agilent Technologies Inc.
PerkinElmer Inc.
Eurofins Scientific
DNAnexus Inc.
BGI Group
Waters Corporation
DNASTAR Inc.

第11章附錄

貨幣
先決條件
基準年和預測年時間表
相關人員的主要利益
調查方法
簡稱

圖表目錄

表格列表

簡介目錄

Product Code: KSI061610545

Bioinformatics Market Size:

The Bioinformatics Market is expected to grow from USD 15.134 billion in 2025 to USD 30.361 billion in 2030, at a CAGR of 14.94%.

Bioinformatics represents the convergence of computational science and biological research, employing sophisticated analytical tools to process and interpret complex biological datasets. This interdisciplinary field encompasses the computational analysis of gene and protein functions, evolutionary relationship mapping, and three-dimensional protein structure prediction, establishing itself as an indispensable component of modern biological research and medical applications.

Market Dynamics and Industry Context

The bioinformatics sector has emerged as a critical enabler of biological research, driven by the exponential growth of data generated through advanced sequencing technologies and protein analysis methodologies. The field's importance stems from the fundamental need to manage, interpret, and derive meaningful insights from massive biological datasets that exceed traditional analytical capabilities.

Modern biological research generates unprecedented volumes of genomic, proteomic, and metabolomic data requiring sophisticated computational infrastructure and specialized analytical algorithms. This data complexity necessitates advanced bioinformatics solutions capable of handling multi-dimensional datasets while providing accurate, actionable insights for medical applications and continued research advancement.

The market's expansion reflects increasing recognition of computational biology's role in accelerating scientific discovery, drug development, and personalized medicine initiatives. As biological research becomes increasingly data-intensive, bioinformatics platforms serve as essential infrastructure supporting everything from basic research to clinical applications.

Growth Drivers and Investment Trends

Public and Private Sector Investment

The bioinformatics market benefits significantly from substantial investments by government agencies and private sector organizations seeking to advance biological research capabilities through computational solutions. These investments reflect strategic recognition of bioinformatics' potential to enable high-quality research outcomes through advanced data analysis and emerging technologies.

Investment patterns demonstrate commitment to developing comprehensive bioinformatics ecosystems that support diverse research applications, from fundamental biological investigations to applied medical research. This financial backing enables development of sophisticated analytical platforms, database infrastructure, and computational resources necessary for complex biological data analysis.

The public sector's involvement in bioinformatics funding particularly emphasizes the field's importance for national research priorities, public health initiatives, and scientific competitiveness. Private sector investments complement government funding by driving innovation in commercial bioinformatics solutions and specialized analytical services.

Market Constraints and Implementation Challenges

Technology Cost Barriers

The bioinformatics industry faces significant challenges related to the high costs associated with advanced analytical equipment and sophisticated software platforms. Next-generation sequencing technologies and associated computational infrastructure require substantial financial investments that can limit market accessibility for smaller organizations.

Genomics instrumentation represents a particularly significant cost consideration, with advanced systems requiring premium pricing that reflects their sophisticated features and analytical capabilities. The financial requirements for acquiring multiple genomic instruments create substantial barriers for smaller pharmaceutical companies and research institutions operating with limited budgets.

These cost constraints create market segmentation where only well-funded organizations can fully leverage cutting-edge bioinformatics capabilities, potentially limiting broader market expansion and innovation diffusion throughout the research community.

Technical Complexity and Usability Challenges

The bioinformatics market confronts ongoing challenges related to software usability and technical accessibility. Many bioinformatics applications require extensive computational expertise, creating barriers for experimental researchers who lack specialized programming skills but need access to analytical capabilities.

The disconnect between sophisticated analytical capabilities and user-friendly interfaces limits broader adoption of bioinformatics tools within the research community. Most experimental researchers operate without formal bioinformatics training, making intuitive, accessible software design crucial for market expansion.

Current bioinformatics platforms often lack appropriate user interfaces that bridge the gap between computational complexity and practical research applications. This usability gap constrains market growth by limiting adoption among researchers who could benefit from bioinformatics capabilities but lack technical expertise to navigate complex software environments.

Strategic Market Outlook

The bioinformatics market operates within a dynamic environment characterized by increasing data complexity offset by cost and accessibility challenges. Success requires balancing advanced analytical capabilities with user-friendly interfaces while addressing cost barriers that limit market participation across diverse research organizations.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Bioinformatics Market Segmentation:

By Application

Drug Discovery and Development
Personalized and Preventive Medicine
Genomics and Genetic Research
Molecular Medicine
Clinical Diagnostics
Forensic and Environmental Bioinformatics
Others

By Biological Data Type

Genomics
Transcriptomics
Proteomics
Metabolomics
Pharmacogenomics
Cheminformatics
Epigenomics
Others

By End-User

Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Agricultural Research Organizations
Hospitals and Clinics
Contract Research Organizations (CROs)
Others

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
Japan
India
South Korea
Taiwan
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. BIOINFORMATICS MARKET BY APPLICATION

5.1. Introduction
5.2. Drug Discovery and Development
5.3. Personalized and Preventive Medicine
5.4. Genomics and Genetic Research
5.5. Molecular Medicine
5.6. Clinical Diagnostics
5.7. Forensic and Environmental Bioinformatics
5.8. Others

6. BIOINFORMATICS MARKET BY BIOLOGICAL DATA TYPE

6.1. Introduction
6.2. Genomics
6.3. Transcriptomics
6.4. Proteomics
6.5. Metabolomics
6.6. Pharmacogenomics
6.7. Cheminformatics
6.8. Epigenomics
6.9. Others

7. BIOINFORMATICS MARKET BY END-USER

7.1. Introduction
7.2. Pharmaceutical and Biotechnology Companies
7.3. Academic and Research Institutes
7.4. Agricultural Research Organizations
7.5. Hospitals and Clinics
7.6. Contract Research Organizations (CROs)
7.7. Others

8. BIOINFORMATICS MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. By Application
- 8.2.2. By Biological Data Type
- 8.2.3. By End-User
- 8.2.4. By Country
  - 8.2.4.1. USA
  - 8.2.4.2. Canada
  - 8.2.4.3. Mexico
8.3. South America
- 8.3.1. By Application
- 8.3.2. By Biological Data Type
- 8.3.3. By End-User
- 8.3.4. By Country
  - 8.3.4.1. Brazil
  - 8.3.4.2. Argentina
  - 8.3.4.3. Others
8.4. Europe
- 8.4.1. By Application
- 8.4.2. By Biological Data Type
- 8.4.3. By End-User
- 8.4.4. By Country
  - 8.4.4.1. United Kingdom
  - 8.4.4.2. Germany
  - 8.4.4.3. France
  - 8.4.4.4. Spain
  - 8.4.4.5. Others
8.5. Middle East and Africa
- 8.5.1. By Application
- 8.5.2. By Biological Data Type
- 8.5.3. By End-User
- 8.5.4. By Country
  - 8.5.4.1. Saudi Arabia
  - 8.5.4.2. UAE
  - 8.5.4.3. Others
8.6. Asia Pacific
- 8.6.1. By Application
- 8.6.2. By Biological Data Type
- 8.6.3. By End-User
- 8.6.4. By Country
  - 8.6.4.1. China
  - 8.6.4.2. Japan
  - 8.6.4.3. India
  - 8.6.4.4. South Korea
  - 8.6.4.5. Taiwan
  - 8.6.4.6. Others